Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
AC BioScience SA logo — AC BioScience is a biotech start-up committed to finding nov...

AC BioScience SA

AC BioScience is a biotech start-up committed to finding novel cancer treatments, based in Lausanne.

Founded 2017 Switzerland Ecublens, Switzerland 1 employees Seed Total: $7.45M Biotechnology, Health and Wellness +1

General Information

Company Name AC BioScience SA
Founded Year 2017
Location Switzerland Ecublens, Switzerland +1
Employees 1
Industries Biotechnology, Health and Wellness, Life Sciences
Funding Stage Seed
Social

Get notified when AC BioScience SA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About AC BioScience SA

AC BioScience is a biotech start-up committed to finding novel cancer treatments, based in Lausanne. The company was initiated in 2017 by Andreas Schläpfer and Professor Christian Auclair, a distinguished figure in molecular oncology. AC BioScience is located in the EPFL Innovation Park close to Lausanne and marked its one-year anniversary in March 2018. The start-up recently secured a Fr. 2.50M Seed Round investment on 25 August 2022. With an exceptional business model and visionary mission to revolutionize cancer therapies, AC BioScience demonstrates promising potential within the biotechnology industry.

Taxonomy: Biotech, Cancer treatments, Molecular oncology, Therapeutics, Innovation, Start-up, EPFL Innovation Park, Lausanne, Research and development, Drug discovery, Medical science, Inventive therapies, Cancer research

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• - 25 Aug 2022
Grant •••••• - 27 Feb 2022
Debt Financing •••••• - 12 Oct 2021
Seed Round •••••• - 17 Dec 2020
Seed Round •••••• - 25 May 2020

View All 6 Funding Rounds

AC BioScience SA Alternatives & Competitors

AC BioScience SA vs
Anticancer Bioscience
Anticancer Bioscience China

Applying our synthetic lethality expertise for better cancer therapies

Seed
17 employees
Biotechnology, Health Care
AC BioScience SA vs
Compendia Bioscience
Compendia Bioscience

Harnessing global cancer genomic data to enhance diagnostics and treatments for better patient outco...

Seed
Biotechnology
AC BioScience SA vs
Mablink Bioscience
Mablink Bioscience

Pioneering a new era in cancer therapy with innovative Antibody Drug Conjugates.

Series A
Biotechnology, Pharmaceutical

FAQ About AC BioScience SA

AC BioScience is a biotech start-up committed to finding novel cancer treatments, based in Lausanne.
AC BioScience SA was founded in 2017.
AC BioScience SA is headquartered in Ecublens, Switzerland.
AC BioScience SA operates in the following industries: Biotechnology, Health and Wellness, Life Sciences.
AC BioScience SA has approximately 1 employees.
AC BioScience SA has completed 6 funding rounds, raising a total of $7.45M. The latest funding stage is Seed.
Top alternatives and competitors to AC BioScience SA include Anticancer Bioscience, Compendia Bioscience, Mablink Bioscience, Blaze Bioscience, Delaware BioScience Association. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AC BioScience SA and Anticancer Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors AC BioScience SA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes